United States Prostate Cancer Diagnostics Market by Manufacturers, States, Type and Application, Forecast to 2022

Global Info Research
119 Pages
"The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer."


Scope of the Report:
This report focuses on the Prostate Cancer Diagnostics in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Market Segment by Type, covers
Tumor Biomarker Tests
Imaging
Biopsy
Other

Market Segment by Applications, can be divided into
< 55
55-75
> 75

There are 17 Chapters to deeply display the United States Prostate Cancer Diagnostics market.

Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Prostate Cancer Diagnostics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Prostate Cancer Diagnostics, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Prostate Cancer Diagnostics market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Prostate Cancer Diagnostics Research Findings and Conclusion, Appendix, methodology and data source.

Table of Contents
1 Market Overview
1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Tumor Biomarker Tests
1.2.2 Imaging
1.2.3 Biopsy
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 < 55
1.3.2 55-75
1.3.3 > 75
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genomic Health
2.1.1 Profile
2.1.2 Prostate Cancer Diagnostics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Genomic Health News
2.2 Abbott
2.2.1 Profile
2.2.2 Prostate Cancer Diagnostics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Abbott News
2.3 OPKO
2.3.1 Profile
2.3.2 Prostate Cancer Diagnostics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 OPKO News
2.4 Siemens Healthcare
2.4.1 Profile
2.4.2 Prostate Cancer Diagnostics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Siemens Healthcare News
2.5 DiaSorin
2.5.1 Profile
2.5.2 Prostate Cancer Diagnostics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 DiaSorin News
2.6 bioMeriux
2.6.1 Profile
2.6.2 Prostate Cancer Diagnostics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 bioMeriux News
2.7 Roche
2.7.1 Profile
2.7.2 Prostate Cancer Diagnostics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Roche News
2.8 MDx Health
2.8.1 Profile
2.8.2 Prostate Cancer Diagnostics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 MDx Health News
2.9 Beckman Coulter
2.9.1 Profile
2.9.2 Prostate Cancer Diagnostics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Beckman Coulter News
2.10 Myriad Genetics
2.10.1 Profile
2.10.2 Prostate Cancer Diagnostics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Myriad Genetics News
2.11 Ambry Genetics
2.11.1 Profile
2.11.2 Prostate Cancer Diagnostics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Ambry Genetics News
3 United States Prostate Cancer Diagnostics Market Competition, by Manufacturer
3.1 United States Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Prostate Cancer Diagnostics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share
3.4.2 Top 5 Prostate Cancer Diagnostics Manufacturer Market Share
3.5 Market Competition Trend
4 United States Prostate Cancer Diagnostics Market Analysis by States
4.1 United States Prostate Cancer Diagnostics Sales Market Share by States
4.2 United States Prostate Cancer Diagnostics Sales by States (2012-2017)
4.3 United States Prostate Cancer Diagnostics Revenue (Value) by States (2012-2017)
5 United States Market Segmentation Prostate Cancer Diagnostics by Type
5.1 United States Prostate Cancer Diagnostics Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 United States Prostate Cancer Diagnostics Sales and Market Share by Type (2012-2017)
5.1.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
5.2 Tumor Biomarker Tests Sales Growth and Price
5.2.1 United States Tumor Biomarker Tests Sales Growth (2012-2017)
5.2.2 United States Tumor Biomarker Tests Price (2012-2017)
5.3 Imaging Sales Growth and Price
5.3.1 United States Imaging Sales Growth (2012-2017)
5.3.2 United States Imaging Price (2012-2017)
5.4 Biopsy Sales Growth and Price
5.4.1 United States Biopsy Sales Growth (2012-2017)
5.4.2 United States Biopsy Price (2012-2017)
5.5 Other Sales Growth and Price
5.5.1 United States Other Sales Growth (2012-2017)
5.5.2 United States Other Price (2012-2017)
6 United States Market Segmentation Prostate Cancer Diagnostics by Application
6.1 United States Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
6.2 < 55 Sales Growth (2012-2017)
6.3 55-75 Sales Growth (2012-2017)
6.4 > 75 Sales Growth (2012-2017)
7 California Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
7.1 California Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
7.2 California Prostate Cancer Diagnostics Sales and Market Share by Type
7.3 California Prostate Cancer Diagnostics Sales by Application (2012-2017)
8 New York Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
8.1 New York Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Prostate Cancer Diagnostics Sales and Market Share by Type
8.3 New York Prostate Cancer Diagnostics Sales by Application (2012-2017)
9 Texas Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
9.1 Texas Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Prostate Cancer Diagnostics Sales and Market Share by Type
9.3 Texas Prostate Cancer Diagnostics Sales by Application (2012-2017)
10 Florida Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
10.1 Florida Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Prostate Cancer Diagnostics Sales and Market Share by Type
10.3 Florida Prostate Cancer Diagnostics Sales by Application (2012-2017)
11 Illinois Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
11.1 Illinois Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Prostate Cancer Diagnostics Sales and Market Share by Type
11.3 Illinois Prostate Cancer Diagnostics Sales by Application (2012-2017)
12 Prostate Cancer Diagnostics Market Forecast (2017-2022)
12.1 United States Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2017-2022)
12.2 Prostate Cancer Diagnostics Market Forecast by States (2017-2022)
12.3 Prostate Cancer Diagnostics Market Forecast by Type (2017-2022)
12.4 Prostate Cancer Diagnostics Market Forecast by Application (2017-2022)
13 Prostate Cancer Diagnostics Manufacturing Cost Analysis
13.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Prostate Cancer Diagnostics Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2016
14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source


List of Tables and Figures

Figure Prostate Cancer Diagnostics Picture
Table Product Specifications of Prostate Cancer Diagnostics
Figure United States Sales Market Share of Prostate Cancer Diagnostics by Types in 2016
Table Types of Prostate Cancer Diagnostics
Figure Tumor Biomarker Tests Picture
Table Major Manufacturers of Tumor Biomarker Tests
Figure Imaging Picture
Table Major Manufacturers of Imaging
Figure Biopsy Picture
Table Major Manufacturers of Biopsy
Figure Other Picture
Table Major Manufacturers of Other
Table United States Prostate Cancer Diagnostics Sales Market Share by Applications in 2016
Table Applications of Prostate Cancer Diagnostics
Figure < 55 Picture
Figure 55-75 Picture
Figure > 75 Picture
Figure California Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Table Genomic Health Basic Information, Manufacturing Base and Competitors
Table Genomic Health Prostate Cancer Diagnostics Type and Applications
Table Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Prostate Cancer Diagnostics Type and Applications
Table Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OPKO Basic Information, Manufacturing Base and Competitors
Table OPKO Prostate Cancer Diagnostics Type and Applications
Table OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Prostate Cancer Diagnostics Type and Applications
Table Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table DiaSorin Basic Information, Manufacturing Base and Competitors
Table DiaSorin Prostate Cancer Diagnostics Type and Applications
Table DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table bioMeriux Basic Information, Manufacturing Base and Competitors
Table bioMeriux Prostate Cancer Diagnostics Type and Applications
Table bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Prostate Cancer Diagnostics Type and Applications
Table Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MDx Health Basic Information, Manufacturing Base and Competitors
Table MDx Health Prostate Cancer Diagnostics Type and Applications
Table MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table Beckman Coulter Prostate Cancer Diagnostics Type and Applications
Table Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Prostate Cancer Diagnostics Type and Applications
Table Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ambry Genetics Basic Information, Manufacturing Base and Competitors
Table Ambry Genetics Prostate Cancer Diagnostics Type and Applications
Table Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure United States Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure United States Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table United States Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure United States Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2015
Figure United States Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Table United States Prostate Cancer Diagnostics Price by Manufacturers (2016-2017)
Figure Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2016
Figure Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2017
Figure Top 5 Prostate Cancer Diagnostics Manufacturer Market Share in 2016
Figure Top 5 Prostate Cancer Diagnostics Manufacturer Market Share in 2017
Figure United States Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table United States Prostate Cancer Diagnostics Sales by States (2012-2017)
Table United States Prostate Cancer Diagnostics Sales Market Share by States (2012-2017)
Figure United States 2012 Prostate Cancer Diagnostics Sales Market Share by States
Figure United States 2016 Prostate Cancer Diagnostics Sales Market Share by States
Figure United States Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Table United States Prostate Cancer Diagnostics Revenue by States (2012-2017)
Table United States Prostate Cancer Diagnostics Revenue Market Share by States (2012-2017)
Table United States 2012 Prostate Cancer Diagnostics Revenue Market Share by States
Table United States 2016 Prostate Cancer Diagnostics Revenue Market Share by States
Table United States Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Sales Share by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Revenue by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Revenue Share by Type (2012-2017)
Figure United States Tumor Biomarker Tests Sales Growth (2012-2017)
Figure United States Tumor Biomarker Tests Price (2012-2017)
Figure United States Imaging Sales Growth (2012-2017)
Figure United States Imaging Price (2012-2017)
Figure United States Biopsy Sales Growth (2012-2017)
Figure United States Biopsy Price (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure United States Other Price (2012-2017)
Table United States Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table United States Prostate Cancer Diagnostics Sales Share by Application (2012-2017)
Figure United States < 55 Sales Growth (2012-2017)
Figure United States 55-75 Sales Growth (2012-2017)
Figure United States > 75 Sales Growth (2012-2017)
Figure California Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure California Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table California Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table California Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table California Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table California Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure New York Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure New York Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table New York Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table New York Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table New York Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table New York Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure Texas Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure Texas Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Texas Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Texas Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table Texas Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Texas Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure Florida Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure Florida Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Florida Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Florida Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table Florida Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Florida Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure Illinois Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure Illinois Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Illinois Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Illinois Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table Illinois Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Illinois Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2017-2022)
Table United States Prostate Cancer Diagnostics Sales Forecast by States (2017-2022)
Table United States Prostate Cancer Diagnostics Market Share Forecast by States (2017-2022)
Table United States Prostate Cancer Diagnostics Sales Forecast by Type (2017-2022)
Table United States Prostate Cancer Diagnostics Market Share Forecast by Type (2017-2022)
Table United States Prostate Cancer Diagnostics Sales Forecast by Application (2017-2022)
Table United States Prostate Cancer Diagnostics Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Diagnostics
Figure Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure Prostate Cancer Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2016
Table Major Buyers of Prostate Cancer Diagnostics
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

China Food for Special Medical Purpose (FSMP) Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

GIR 2017-11-20 Pharma & Healthcare

Foods for special medical purposes (FSMP) are a sub-category of foods intended for particular nutrit...Read More

China Fibrinogen Concentrate Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

GIR 2017-11-20 Pharma & Healthcare

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. F...Read More

China Phenylketonuria (PKU) Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

GIR 2017-11-20 Pharma & Healthcare

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of me...Read More

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.